USNA Q3'26 Earnings: EPS estimate is 0.11 USD

What happened

USANA Health Sciences is scheduled to report its Q3'26 results on November 03, after the market closes, with disclosure expected at 4:00 PM ET. The supplied headline gives an earnings-per-share estimate of 0.11 USD; the revenue estimate is 217.42 million USD.

Confirmed

Global impact / market context

The report will show whether USANA’s sales and earnings matched expectations. Revenue below the 217.42 million USD estimate could indicate weaker product demand, while earnings below 0.11 USD per share could constrain cash generated for operations or investment; stronger results could support confidence in its business outlook.

Analyst inference

USANA’s Q3'26 results are due after the market closes, with revenue estimated at 217.42 million USD and earnings per share, or profit allocated to each share, expected at 0.11 USD. These estimates set expectations; reported results versus them can shape investor views of the company’s sales and profitability.

Analyst inference

What to watch

1. Compare reported revenue with the 217.42 million USD estimate; a shortfall would suggest sales were weaker than forecast and could limit funds available for business spending. Analyst inference
2. Compare earnings per share with 0.11 USD, and check management’s explanation for any gap; earnings per share divides profit by the number of shares. Analyst inference
3. The company is scheduled to release results November 03 after the market closes, with disclosure expected at 4:00 PM ET; the article provides no actual results. Confirmed

Evidence

• Original source link unavailable